Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 711-720 of 2932 for cancer

Edit search filters
  1. Study Of Tirabrutinib Vs Rituximab/Temozolomide For Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Phase 2 Study Of CPI-0610 With And Without Ruxolitinib In Patients With Myelofibrosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL

  3. Breast MR

    Rochester, MN

  4. Safety Of MT-401-OTS In Patients With Relapsed AML Or MDS

    Jacksonville, FL

  5. 3D Ultrasound For The Imaging Of Axillary Lymph Nodes In Patients With Breast Cancer

    Rochester, MN

  6. A Vaccine (PDS0101) Alone Or In Combination With Pembrolizumab For The Treatment Of Locally Advanced Human Papillomavirus-Associated Oropharynx Cancer

    Rochester, MN

  7. PF-07284892 In Participants With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. Pembrolizumab With Or Without Anetumab Ravtansine In Treating Patients With Mesothelin-Positive Pleural Mesothelioma

    Jacksonville, FL, Rochester, MN

  9. Effect Of Tumor Treating Fields (TTFields, 150 KHz) As Front-Line Treatment Of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine And Nab-paclitaxel (PANOVA-3)

    Jacksonville, FL

  10. TheraSphere With And Without Durvalumab And Tremelimumab For HCC

    Jacksonville, FL

.

Mayo Clinic Footer